borderline significantP < 0.05
And at best, reasonably expected data from that number (using 62% vs 50% success rates) might show a marginal advantage of successfully using an AVG over an AVF at a borderline significant P < 0.05 (but not P < 0.01).
And at best, reasonably expected data from that number (using 62% vs 50% success rates) might show a marginal advantage of successfully using an AVG over an AVF at a borderline significant P < 0.05 (but not P < 0.01).